Julie Zhen Qin Wu

Array ( [id] => 11218854 [patent_doc_number] => 09447183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'IL-1 binding proteins' [patent_app_type] => utility [patent_app_number] => 14/107988 [patent_app_country] => US [patent_app_date] => 2013-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92129 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14107988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9519091 [patent_doc_number] => 20140155583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'MONOCLONAL ANTIBODIES AND SINGLE CHAIN ANTIBODY FRAGMENTS AGAINST CELL-SURFACE PROSTATE SPECIFIC MEMBRANE ANTIGEN' [patent_app_type] => utility [patent_app_number] => 14/105808 [patent_app_country] => US [patent_app_date] => 2013-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9848 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14105808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10580969 [patent_doc_number] => 09303085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'IL-1 binding proteins' [patent_app_type] => utility [patent_app_number] => 14/104991 [patent_app_country] => US [patent_app_date] => 2013-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92120 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14104991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568755 [patent_doc_number] => 20140186468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'DIAGNOSING SUBSETS OF TRIPLE-NEGATIVE BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 14/099266 [patent_app_country] => US [patent_app_date] => 2013-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 38624 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14099266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9518197 [patent_doc_number] => 20140154689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'ANALYSIS OF CIRCULATING TUMOR CELLS AS DIAGNOSTIC AND PREDICTIVE BIOMARKERS FOR METASTATIC CANCERS' [patent_app_type] => utility [patent_app_number] => 14/098112 [patent_app_country] => US [patent_app_date] => 2013-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9092 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14098112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656482 [patent_doc_number] => 20160002626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'TOX INHIBITION FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/647699 [patent_app_country] => US [patent_app_date] => 2013-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6698 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561192 [patent_doc_number] => 20140178906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST PCBP-1 ANTIGENS, AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/077967 [patent_app_country] => US [patent_app_date] => 2013-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16845 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14077967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421266 [patent_doc_number] => 20140105918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF PROSTATE CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 14/050262 [patent_app_country] => US [patent_app_date] => 2013-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35752 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14050262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491774 [patent_doc_number] => 20140142180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'METHODS OF TREATING TUMORS HAVING ELEVATED MCT1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/046643 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 70408 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9603580 [patent_doc_number] => 20140200261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES' [patent_app_type] => utility [patent_app_number] => 14/041011 [patent_app_country] => US [patent_app_date] => 2013-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 184095 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14041011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9383915 [patent_doc_number] => 20140087397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'BIOMARKERS FOR FANCONI ANEMIA' [patent_app_type] => utility [patent_app_number] => 14/034197 [patent_app_country] => US [patent_app_date] => 2013-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13981 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421282 [patent_doc_number] => 20140105933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'METHODS FOR ASSESSING CANCER RECURRENCE' [patent_app_type] => utility [patent_app_number] => 14/024348 [patent_app_country] => US [patent_app_date] => 2013-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13306 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14024348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11331725 [patent_doc_number] => 09522961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Protein complexes and methods of manufacturing bispecific antibodies using the protein complexes' [patent_app_type] => utility [patent_app_number] => 14/023538 [patent_app_country] => US [patent_app_date] => 2013-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5749 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14023538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363712 [patent_doc_number] => 20140073585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'PEPTIDE INHIBITORS OF HAUSP DEUBIQUITINASE' [patent_app_type] => utility [patent_app_number] => 13/971744 [patent_app_country] => US [patent_app_date] => 2013-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24351 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13971744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10306523 [patent_doc_number] => 20150191524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-09 [patent_title] => 'ENGINEERING T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/417434 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 31294 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10274224 [patent_doc_number] => 20150159222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'MARKERS ASSOCIATED WITH HUMAN DOUBLE MINUTE 2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/413510 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20486 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11750387 [patent_doc_number] => 09708389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Method for preparing homodimer protein mixture by using charge repulsion effect' [patent_app_type] => utility [patent_app_number] => 14/416817 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9467 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295352 [patent_doc_number] => 20140038986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'MARKERS ASSOCIATED WITH HUMAN DOUBLE MINUTE 2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/950881 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18255 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13950881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977055 [patent_doc_number] => 09023362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Immunological compositions as cancer therapeutics' [patent_app_type] => utility [patent_app_number] => 13/943159 [patent_app_country] => US [patent_app_date] => 2013-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19625 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9294002 [patent_doc_number] => 20140037636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'ANTI-CD98 ANTIBODY PROCESSES' [patent_app_type] => utility [patent_app_number] => 13/940640 [patent_app_country] => US [patent_app_date] => 2013-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20943 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13940640 [rel_patent_id] =>[rel_patent_doc_number] =>)